Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Seroma 3Melanoma 2Breast Neoplasms 2Postoperative Complications 1Lymphoma, Follicular 1Carcinoma, Squamous Cell 1

Interventions

Ipilimumab 98pembrolizumab 84Nivolumab 82aldesleukin 51Cyclophosphamide 49Interleukin-2 38fludarabine phosphate 31Vemurafenib 31Dacarbazine 31dabrafenib 29trametinib 28Temozolomide 26fludarabine 25CTLA-4 Antigen 18Bevacizumab 18Radiosurgery 15Paclitaxel 15Carboplatin 14encorafenib 13binimetinib 13Introns 13talimogene laherparepvec 12Radiotherapy 12Interferon alpha-2 12spartalizumab 11cobimetinib 10atezolizumab 10sargramostim 9peginterferon alfa-2b 9montanide ISA 51 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Melanoma × Fibrin Tissue Adhesive × Clear all
NCT00504582 2023-05-09

Fibrin Melanoma Axillary Node Study in Patients With Melanoma

M.D. Anderson Cancer Center

Phase NA Completed
121 enrolled 10 charts
Dermatologic

Melanoma, Seroma

NCT00324272 2011-08-11

Post-Operative Drainage Following Lymph Node Dissection

Oxford University Hospitals NHS Trust

Phase 4 Completed
74 enrolled 16 charts
Dermatologic

Carcinoma, Squamous Cell, Melanoma, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡